Aureus Asset Management’s iShares US Medical Devices ETF IHI Stock Holding History

Aureus Asset Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$288K	Buy	+5,400	New	+$317K	0.02%	186

Other funds holding IHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Aureus Asset Management's IHI Position: Q1 2026 in Review

Aureus Asset Management opened a new position in iShares US Medical Devices ETF (IHI) in Q1 2026: 5,400 shares worth $288K. The stake represents 0.02% of the portfolio and ranks #186 among its holdings.

503 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

Aureus Asset Management held 5,400 shares of iShares US Medical Devices ETF worth $288K as of Q1 2026.
iShares US Medical Devices ETF was a new Aureus Asset Management position in Q1 2026.
iShares US Medical Devices ETF made up 0.02% of Aureus Asset Management's portfolio in Q1 2026, its #186 holding.
503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Aureus Asset Management's 13F filing for Q1 2026, filed 13 May 2026.